*Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Baltimore, MD; †Clinical Sciences, Family Health International 360, Durham, NC; ‡Case Western Reserve University, Cleveland, OH; and §Johns Hopkins University School of Medicine, Baltimore, MD.
J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):390-6. doi: 10.1097/QAI.0000000000000006.
Analysis of samples from Uganda using serologic HIV incidence assays reveal that individuals with subtype D infection often have weak humoral immune responses to HIV infection. It is unclear whether this reflects a poor initial response to infection or a waning antibody response later in infection.
Samples (N = 2614) were obtained from 114 women aged 18-45 years in the Ugandan Genital Shedding and Disease Progression Study cohort (2001-2009; 82 subtype A, 32 subtype D; median 23 samples/women, range 3-41 samples, median follow-up of 6.6 years). Samples were analyzed using the BED capture immunoassay (cutoff, 0.8 OD-n) and the avidity assay (cutoff, 90% Avidity Index). Antibody maturation was assessed by having the BED capture enzyme immunoassay (BED-CEIA) or avidity value exceed the assay cutoff 1 or 2 years after infection. The waning antibody response was measured by having the BED-CEIA or avidity value fall >20% below the maximum value.
For the BED-CEIA, 8 women with subtype A infection and 3 women with subtype D infection never progressed previously the cutoff value (median, 5.9 years follow-up after infection). Six women with subtype D infection never achieved an avidity index >90%. Subtype did not impact the proportion of women whose assay values regressed by >20% of the maximal value (for BED-CEIA: 33% for A, 41% for D, P = 0.51; for avidity: 1% for A, 6% for D, P = 0.19).
The higher frequency of misclassification of individuals with long-term subtype D infection as recently infected using serologic incidence assays reflects a weak initial antibody response to HIV infection that is sustained over time.
使用血清学 HIV 发病率检测分析来自乌干达的样本表明,感染亚型 D 的个体对 HIV 感染通常表现出较弱的体液免疫反应。目前尚不清楚这是反映了对感染的初始反应不佳,还是在感染后期抗体反应减弱。
从乌干达生殖器脱落和疾病进展研究队列(2001-2009 年;82 例亚型 A,32 例亚型 D;中位数 23 个样本/女性,范围 3-41 个样本,中位数随访 6.6 年)中获得了 114 名 18-45 岁女性的样本(N=2614)。使用 BED 捕获免疫测定法(临界值 0.8 OD-n)和亲和力测定法(临界值 90%亲和力指数)分析样本。通过 BED 捕获酶免疫测定法(BED-CEIA)或亲和力值在感染后 1 或 2 年超过检测临界值,评估抗体成熟情况。通过 BED-CEIA 或亲和力值下降超过最大值的 20%来测量抗体反应下降。
对于 BED-CEIA,8 例感染亚型 A 的女性和 3 例感染亚型 D 的女性从未在检测临界值之前进展(中位数,感染后 5.9 年随访)。6 例感染亚型 D 的女性从未达到 >90%的亲和力指数。亚型未影响检测值下降超过最大值的 20%的女性比例(对于 BED-CEIA:A 为 33%,D 为 41%,P=0.51;对于亲和力:A 为 1%,D 为 6%,P=0.19)。
使用血清学发病率检测分析对长期感染亚型 D 的个体进行分类时,误将其归类为近期感染的频率较高,这反映了对 HIV 感染的初始抗体反应较弱,并且持续时间较长。